Open AccessSurrogate consent for dementia research
Author(s) -
S.Y.H. Kim,
H. M. Kim,
Kenneth M. Langa,
Jason Karlawish,
David S. Knopman,
Paul S. Appelbaum
Publication year - 2009
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/01.wnl.0000339039.18931.a2
Subject(s) - informed consent , surrogate endpoint , dementia , ethnic group , psychology , family medicine , medicine , gerontology , disease , alternative medicine , law , political science , pathology
Research in novel therapies for Alzheimer disease (AD) relies on persons with AD as research subjects. Because AD impairs decisional capacity, informed consent often must come from surrogates, usually close family members. But policies for surrogate consent for research remain unsettled after decades of debate.